Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Common Equity (2016 - 2025)

Historic Common Equity for Ekso Bionics Holdings (EKSO) over the last 14 years, with Q3 2025 value amounting to $9.7 million.

  • Ekso Bionics Holdings' Common Equity fell 3490.92% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year decrease of 3490.92%. This contributed to the annual value of $12.7 million for FY2024, which is 80.12% up from last year.
  • Per Ekso Bionics Holdings' latest filing, its Common Equity stood at $9.7 million for Q3 2025, which was down 3490.92% from $10.9 million recorded in Q2 2025.
  • Ekso Bionics Holdings' 5-year Common Equity high stood at $41.0 million for Q1 2021, and its period low was $9.7 million during Q3 2025.
  • Its 5-year average for Common Equity is $22.7 million, with a median of $17.8 million in 2023.
  • In the last 5 years, Ekso Bionics Holdings' Common Equity surged by 14330000.0% in 2021 and then tumbled by 5045.2% in 2023.
  • Over the past 5 years, Ekso Bionics Holdings' Common Equity (Quarter) stood at $37.2 million in 2021, then crashed by 31.64% to $25.4 million in 2022, then tumbled by 50.45% to $12.6 million in 2023, then grew by 0.8% to $12.7 million in 2024, then dropped by 23.83% to $9.7 million in 2025.
  • Its last three reported values are $9.7 million in Q3 2025, $10.9 million for Q2 2025, and $12.7 million during Q1 2025.